---
figid: PMC6767532__DTH-32-na-g001
figtitle: Cyclooxygenase (COX) pathway and prostaglandin E2 (PGE2) signaling
organisms:
- Homo sapiens
- Mus musculus
organisms_ner:
- Homo sapiens
- Mus musculus
- Drosophila melanogaster
pmcid: PMC6767532
filename: DTH-32-na-g001.jpg
figlink: /pmc/articles/PMC6767532/figure/dth12800-fig-0001/
number: F1
caption: The cyclooxygenase (COX) pathway and prostaglandin E2 (PGE2) signaling. 15‐PGDH,
  15‐hydroxyprostaglandin dehydrogenase; AA, arachidonic acid; AC, adenylate cyclase;
  Ca2+, calcium; cAMP, cyclic adenosine monophosphate; cPGES, cytosolic PGE2 synthase;
  COX‐1, cyclooxygenase 1; COX‐2, cyclooxygenase 2; EP1, EP2, EP3 and EP4, PGE2 receptor‐1,
  ‐2, ‐3, and ‐4; G1, G4 and G5, G‐protein receptor‐1, ‐4, and ‐5; mPGES 1 & 2, microsomal
  prostaglandin E synthase‐1 and ‐2; NSAIDs, non‐steroidal anti‐inflammatory drugs;
  PGD2, prostaglandin D2; PGE2, prostaglandin E2; PGES, prostaglandin E synthase;
  PGF2α, prostaglandin F2α; PGH2, prostaglandin H2
papertitle: 'Treatment of actinic keratosis through inhibition of cyclooxygenase‐2:
  Potential mechanism of action of diclofenac sodium 3% in hyaluronic acid 2.5%.'
reftext: Gareth J. Thomas, et al. Dermatol Ther. 2019 May-Jun;32(3):e12800.
year: '2019'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.8776923
figid_alias: PMC6767532__F1
figtype: Figure
redirect_from: /figures/PMC6767532__F1
ndex: ede5f543-debc-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6767532__DTH-32-na-g001.html
  '@type': Dataset
  description: The cyclooxygenase (COX) pathway and prostaglandin E2 (PGE2) signaling.
    15‐PGDH, 15‐hydroxyprostaglandin dehydrogenase; AA, arachidonic acid; AC, adenylate
    cyclase; Ca2+, calcium; cAMP, cyclic adenosine monophosphate; cPGES, cytosolic
    PGE2 synthase; COX‐1, cyclooxygenase 1; COX‐2, cyclooxygenase 2; EP1, EP2, EP3
    and EP4, PGE2 receptor‐1, ‐2, ‐3, and ‐4; G1, G4 and G5, G‐protein receptor‐1,
    ‐4, and ‐5; mPGES 1 & 2, microsomal prostaglandin E synthase‐1 and ‐2; NSAIDs,
    non‐steroidal anti‐inflammatory drugs; PGD2, prostaglandin D2; PGE2, prostaglandin
    E2; PGES, prostaglandin E synthase; PGF2α, prostaglandin F2α; PGH2, prostaglandin
    H2
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - COX8A
  - CPOX
  - COX5A
  - COX5B
  - COX6C
  - COX7C
  - .na.character
  - COX4I1
  - COX4I2
  - COX6A1
  - COX6A2
  - COX6B1
  - COX6B2
  - COX7A1
  - COX7A2
  - COX7B
  - COX7B2
  - COX8C
  - PTGES3
  - PTGES
  - PTGS2
  - COX1
  - PTGS1
  - HPGD
  - PTGER1
  - PGD
  - PHGDH
  - PGF
  - PTGER2
  - SPAG11B
  - PTGER4
  - Cox4i1
  - Ptges3
  - Ptges
  - H2-Aa
  - Ptgs2
  - Ptgs1
  - Hpgd
  - Ptger1
  - Lypd8l
  - Pgd
  - Ptgdr
  - Phgdh
  - Pgf
  - Ptgfr
  - Ptger2
  - Ptger4
  - COX4
  - aa
  - COX2
  - E3
  - ca
  - PGE
  - Prostaglandin
  - Arachidonic acid
  - 15-PGDH H PGE
  - H
  - Leukotrienes
---
